Generic drug companies (e.g., Mylan)
PersonMentions
0
Relationships
0
Events
1
Documents
0
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Research meetings | Global | View |
No documents found for this entity.
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
1
As Recipient
0
Total
1
Request for drug samples for generic development
From:
Generic drug companies...
To:
Celgene
The document describes a pattern of communication where Celgene would refuse to distribute drug samples, citing REMS, and demand written confirmation from the F.D.A. After generic companies provided this, Celgene would then request more 'laborious, irrelevant and time consuming' information to further delay the process.
Process
N/A
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity